Table 3 QSAR model validations values
From: Computational evaluation of some compounds as potential anti-breast cancer agents
Validation parameters | Model 1 | Model 2 | Model 3 | Model 4 |
|---|---|---|---|---|
Friedman LOF | 0.0330700 | 0.034214 | 0.035402 | 0.036218 |
\(R^{2}\) | 0.984748 | 0.984220 | 0.983673 | 0.983296 |
\(R_{{{\text{adj}}}}^{2}\) | 0.981359 | 0.980714 | 0.980044 | 0.979584 |
\(Q_{{{\text{cv}}}}^{2}\) | 0.976276 | 0.973887 | 0.945063 | 0.970229 |
\(R^{2} - Q_{{{\text{cv}}}}^{2}\) | 0.008472 | 0.010333 | 0.03861 | 0.013067 |
\(R_{{{\text{ext}}}}^{2}\) | 0.8240 | |||
\({\text{cR}}_{{\text{p}}}^{2}\) | 0.8200 | |||
Significance-of-regression F-value | 290.545886 | 280.675457 | 271.112245 | 264.901430 |
Min expt. error for non-significant LOF (95%) | 0.06792300 | 0.06908900 | 0.07027700 | 0.07108300 |